Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eisuke Mekada

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Anticancer Research|November 1, 2007
New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting moleculeShingo Miyamoto, Hiroshi Yagi, Fusanori Yotsumoto, et al.
FEBS Letters|February 2, 2012
MIG-13 controls anteroposterior cell migration by interacting with UNC-71/ADM-1 and SRC-1 in Caenorhabditis elegansHitomi Masuda, Kuniaki Nakamura, Nozomu Takata, et al.
The Journal of Biological Chemistry|January 6, 2007
Parasporin-1, a novel cytotoxic protein from Bacillus thuringiensis, induces Ca2+ influx and a sustained elevation of the cytoplasmic Ca2+ concentration in toxin-sensitive cellsHideki Katayama, Yoshitomo Kusaka, Haruo Yokota, et al.
American Journal of Translational Research|November 13, 2012
Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancerNoriyuki Kasai, Kazuhiro Kobayashi, Shinobu Shioya, et al.
Development (Cambridge, England)|October 5, 2007
Sulfated glycosaminoglycans are necessary for Nodal signal transmission from the node to the left lateral plate in the mouse embryoShinya Oki, Ryuju Hashimoto, Yuko Okui, et al.
Cancer Science|October 16, 2010
Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cellsNaohiko Koshikawa, Hiroto Mizushima, Tomoko Minegishi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2006
FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblastsKyoko Kakumoto, Ken Sasai, Taiko Sukezane, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 25, 2011
Development of anti-HB-EGF immunoliposomes for the treatment of breast cancerKaoru Nishikawa, Tomohiro Asai, Hirokazu Shigematsu, et al.
Biochemical and Biophysical Research Communications|October 3, 2006
Loss of HB-EGF in smooth muscle or endothelial cell lineages causes heart malformationDaisuke Nanba, Yumi Kinugasa, Chie Morimoto, et al.
The Journal of Infectious Diseases|May 10, 2002
Elevated levels of anti-CD9 antibodies in the cerebrospinal fluid of patients with subacute sclerosing panencephalitisToko Shimizu, Toyojiro Matsuishi, Ryo Iwamoto, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Anticancer Research|November 1, 2007
New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting moleculeShingo Miyamoto, Hiroshi Yagi, Fusanori Yotsumoto, et al.
FEBS Letters|February 2, 2012
MIG-13 controls anteroposterior cell migration by interacting with UNC-71/ADM-1 and SRC-1 in Caenorhabditis elegansHitomi Masuda, Kuniaki Nakamura, Nozomu Takata, et al.
The Journal of Biological Chemistry|January 6, 2007
Parasporin-1, a novel cytotoxic protein from Bacillus thuringiensis, induces Ca2+ influx and a sustained elevation of the cytoplasmic Ca2+ concentration in toxin-sensitive cellsHideki Katayama, Yoshitomo Kusaka, Haruo Yokota, et al.
American Journal of Translational Research|November 13, 2012
Soluble heparin-binding EGF-like growth factor (HB-EGF) detected by newly developed immuno-PCR method is a clear-cut serological biomarker for ovarian cancerNoriyuki Kasai, Kazuhiro Kobayashi, Shinobu Shioya, et al.
Development (Cambridge, England)|October 5, 2007
Sulfated glycosaminoglycans are necessary for Nodal signal transmission from the node to the left lateral plate in the mouse embryoShinya Oki, Ryuju Hashimoto, Yuko Okui, et al.
Cancer Science|October 16, 2010
Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cellsNaohiko Koshikawa, Hiroto Mizushima, Tomoko Minegishi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2006
FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblastsKyoko Kakumoto, Ken Sasai, Taiko Sukezane, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 25, 2011
Development of anti-HB-EGF immunoliposomes for the treatment of breast cancerKaoru Nishikawa, Tomohiro Asai, Hirokazu Shigematsu, et al.
Biochemical and Biophysical Research Communications|October 3, 2006
Loss of HB-EGF in smooth muscle or endothelial cell lineages causes heart malformationDaisuke Nanba, Yumi Kinugasa, Chie Morimoto, et al.
The Journal of Infectious Diseases|May 10, 2002
Elevated levels of anti-CD9 antibodies in the cerebrospinal fluid of patients with subacute sclerosing panencephalitisToko Shimizu, Toyojiro Matsuishi, Ryo Iwamoto, et al.
Pageof 7